none 10mg (equivalent to 47.35mg zinc picolinate) film coated tablet
dr. zen's research, inc.; importer: n/a; distributor: n/a - zinc - film coated tablet - 10mg (equivalent to 47.35mg zinc picolinate)
none 10 mg (equivalent to 27.45 mg zinc sulfate monohydrate) film-coated tablet
dr. zen's research, inc. - zinc - film-coated tablet - 10 mg (equivalent to 27.45 mg zinc sulfate monohydrate)
none 40 mg (equivalent to 189.40 mg zinc picolinate) film-coated tablet
dr. zen's research, inc.; importer: n/a; distributor: n/a - zinc - film-coated tablet - 40 mg (equivalent to 189.40 mg zinc picolinate)
none capsule
dr. zen's research, inc. - ascorbic acid , zinc - capsule - 500 mg (equi to 562.43mg sodium ascorbate)/10mg (equi. to 70mg zinc gluconate)
none 10 mg chewable tablet
dr. zen's research, inc. - zinc - chewable tablet - 10 mg
none capsule
dr. zen's research, inc. - ascorbic acid , cholecalciferol , zinc - capsule - 500 mg (equivalent to 562.43 mg sodium ascorbate)/ 1,000 iu/10 mg (equivalent to 70 mg zinc gluconate)
none capsule
dr. zen's research, inc. - ascorbic acid , cholecalciferol (vitamin d3) , zinc - capsule - 500 mg (equivalent to 605.20 mg calcium ascorbate)/1,000 iu/10 mg (equivalent to 70 mg zinc gluconate)
none syrup
dr. zen's research, inc. - ascorbic acid , zinc - syrup - 100 mg/10 mg (equivalent to 27.45 mg zinc sulfate monohydrate) per 5 ml (orange flavor)
none chewable tablet
zen's research, inc. - ascorbic acid , zinc - chewable tablet - 500 mg (equivalent to 562.43 mg sodium ascorbate)/ 10 mg (equivalent to 70 mg zinc gluconate)
flumazenil injection, solution
remedyrepack inc. - flumazenil (unii: 40p7xk9392) (flumazenil - unii:40p7xk9392) - flumazenil injection, usp is indicated for the complete or partial reversal of the sedative effects of benzodiazepines in cases where general anesthesia has been induced and/or maintained with benzodiazepines, where sedation has been produced with benzodiazepines for diagnostic and therapeutic procedures, and for the management of benzodiazepine overdose. flumazenil injection, usp is indicated for the reversal of conscious sedation induced with benzodiazepines (see precautions , pediatric use ). flumazenil injection, usp is contraindicated: • in patients with a known hypersensitivity to flumazenil or benzodiazepines. • in patients who have been given a benzodiazepine for control of a potentially life-threatening condition (e.g., control of intracranial pressure or status epilepticus). • in patients who are showing signs of serious cyclic antidepressant overdose (see warnings ). flumazenil acts as a benzodiazepine antagonist, blocks the effects of benzodiazepines in animals and man, antagonizes benzodiazepine reinforcement in animal models, produces dysphoria in normal subjects, and has had no reported abuse in foreign marketing. although flumazenil has a benzodiazepine-like structure it does not act as a benzodiazepine agonist in man and is not a controlled substance.